Neumora Therapeutics | 4:持股變動聲明-高管 Pinto Joshua
Neumora Therapeutics | 4:持股變動聲明-董事 Ho Maykin
Neumora Therapeutics | 4:持股變動聲明-董事 Piacquad David
Neumora Therapeutics | 4:持股變動聲明-董事 Halawa Alaa
Neumora Therapeutics | 4:持股變動聲明-董事 Fust Matthew K
Neumora Therapeutics | 4:持股變動聲明-董事 Burow Kristina
Neumora Therapeutics | 4:持股變動聲明-高管 Aurora Daljit Singh
Neumora Therapeutics | 4:持股變動聲明-高管 Pinto Joshua
Neumora Therapeutics | 4:持股變動聲明-董事 BERNS PAUL L
Neumora Therapeutics | 4:持股變動聲明-高管 Aurora Daljit Singh
Neumora Therapeutics | 4:持股變動聲明-高管 Suh Carol Y.
Neumora Therapeutics | 4:持股變動聲明-高管 Lenz Robert A.
Neumora Therapeutics | 4:持股變動聲明-高管 Milligan Michael Lee
Neumora Therapeutics | 4:持股變動聲明-高管 Gosebruch Henry O
Neumora Therapeutics | SC 13G:超過5%持股股東披露文件-Paul L Berns(5.2%)
Neumora Therapeutics | SC 13G:超過5%持股股東披露文件-SoftBank Group Corp.(5.0%),SB Global Advisers Limited(5.0%)等
Neumora Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%)等
Neumora Therapeutics | 4:持股變動聲明-股東 ARCH Venture Partners XII, LLC
Neumora Therapeutics | 4:持股變動聲明-股東 ARCH Venture Partners X, LLC
Neumora Therapeutics | 4:持股變動聲明-董事 Burow Kristina
暫無數據